Is tesamorelin approved in Canada?

Only as a specific prescription drug product authorized by Health Canada. That authorization covers that drug product, not tesamorelin supplied as research material.

Is research-grade tesamorelin the same as the authorized drug product?

No. The authorized drug product has a DIN, a published monograph and a specified formulation. Research material is supplied against a certificate of analysis for identity and purity, is not manufactured to a drug product specification, and is for in-vitro laboratory use only.

Why is tesamorelin supplied as research material if an approved product exists?

The approved product is a medicine, supplied through pharmacies against a prescription. Laboratory research on the molecule is a separate activity that needs the compound itself rather than a finished drug product, which is what research-grade material is for.

Does Volta's tesamorelin have a Health Canada DIN?

No. A DIN belongs to an authorized drug product, and research material is not one. Any research-grade peptide presented as carrying a DIN is misrepresented.

Compound research hub

Tesamorelin: Research, Handling and Batch Documentation

Tesamorelin is GHRH(1-44) carrying a trans-3-hexenoyl group on its N-terminal tyrosine, an analogue that acts at the GHRH receptor.

Part of Volta's peptides.

Identity and specification

Form: Lyophilized powder
Appearance: White lyophilised powder
Other known names: TH9507
Compound class: GHRH analogue (GHRH receptor agonist)
CAS number: 218949-48-5
Molecular formula: C₂₂₃H₃₇₀N₇₂O₆₉S
Molecular weight: 5,195.9 g/mol
PubChem CID: 44147413
Production: Synthetic, by solid-phase peptide synthesis
Solubility: Soluble in sterile water
Shelf life: 24 months from date of manufacture

Molecular structure, sequence and the published laboratory studies on Tesamorelin are in the compound library entry for Tesamorelin.

Vial sizes available

Every size of Tesamorelin Volta lists, in stock or not. Each is a separate catalogue page with its own batch number and specification table.

Tesamorelin 10mg 10mgBatch #: VPTS10100
In stock
Tesamorelin 20mg 20mgBatch #: VPTS20100
Restocking

Purity and batch documentation

Volta's release specification is >99% (HPLC). That is a threshold we set. >99% is the specification every batch is released to. The figure on a certificate is what a laboratory measured for one lot.

SideChain Analytics reported 99.5% by HPLC-MS/MS on September 27, 2026, lot VPTS10100.
Covers the Tesamorelin 10mg vial.
Read the certificate Verify on lab's website (Verify on SideChain Analytics's website, opens in a new tab)

the complete batch history dataset how each batch is tested laboratories that test peptides independently

Research on Tesamorelin

Comparisons

Handling and stability

Laboratory guides

storage and stability in solution

Regulatory context

Tesamorelin in Canada

Tesamorelin is authorized in Canada only as a prescription drug product. What Volta supplies is research material, not that product, and the two are not interchangeable.

Health Canada has authorized tesamorelin as a prescription drug product, which carries a Drug Identification Number (DIN). Research material is not that product and carries no DIN.
An approved drug product carries a DIN, a monograph, a specified formulation and a manufacturer accountable for it. Research material carries a certificate of analysis for identity and purity and nothing else.
Volta supplies tesamorelin for in-vitro laboratory research only. It is not the authorized drug product, is not dispensed against a prescription, and is not authorised for human use.

Is tesamorelin approved in Canada?: Only as a specific prescription drug product authorized by Health Canada. That authorization covers that drug product, not tesamorelin supplied as research material.
Is research-grade tesamorelin the same as the authorized drug product?: No. The authorized drug product has a DIN, a published monograph and a specified formulation. Research material is supplied against a certificate of analysis for identity and purity, is not manufactured to a drug product specification, and is for in-vitro laboratory use only.
Why is tesamorelin supplied as research material if an approved product exists?: The approved product is a medicine, supplied through pharmacies against a prescription. Laboratory research on the molecule is a separate activity that needs the compound itself rather than a finished drug product, which is what research-grade material is for.
Does Volta's tesamorelin have a Health Canada DIN?: No. A DIN belongs to an authorized drug product, and research material is not one. Any research-grade peptide presented as carrying a DIN is misrepresented.

Regulatory position verified 2026-10-10. Positions change; this page states the date it was last checked rather than implying it is current.

More peptides

Tesamorelin sits in Volta's peptides group, alongside the other compounds of the same composition. The whole range is on the full research catalogue, and the library of comparisons and guides is under peptide research.